Human VPS4B Inhibitor

Patent Status

Patent Pending

Brief Description

Suggested uses

● Treating neurodegenerative disorders like Parkinson's Disease and Alzheimer's Disease by reducing symptoms associated with endosomal-lysosomal and autophagic dysfunction.

● Serving as reagents for activating VPS4 activity in cells, which allows researchers to study the effects of ESCRT pathways in biological systems.

Advantages

● Provides a new class of compounds, activators of VPS4B and/or VPS4A, to address neurodegenerative disorders.

● Offers a research tool for studying the effects of ESCRT pathways.

● Addresses the underlying dysfunction in endosomal-lysosomal and autophagic activity associated with neurodegenerative diseases.

Related Materials